Studies report that 11C-flumazenil (FMZ) PET more specifically localizes the epileptogenic
zone in patients with medically refractory focal epilepsy than 18F-FDG PET. However …

Background: Using 11C-flumazenil (FMZ) PET with correction for partial-volume effect,
reductions of central benzodiazepine receptor (cBZR) binding can be detected reliably in …

BACKGROUND: 11C-flumazenil (FMZ) positron emission tomography (PET) is a new
entrant into the armamentarium for pre-surgical evaluation of patients with intractable …

Reduced signal on [11C]] flumazenil (FMZ) positron emission tomography (PET) is
associated with epileptogenic foci. Linear correlations within individuals between parametric …

In temporal lobe epilepsy (TLE) patients without lesions, major hippocampal sclerosis, or
atrophy on magnetic resonance imaging (MRI), the localizing power of [11C] flumazenil …

Background: Positron emission tomography (PET) with 18F‐fluorodeoxyglucose (FDG)
shows widespread hypometabolism even in temporal lobe epilepsy (TLE) patients with …

Objective: To detect reduced [11C] flumazenil in patients with temporal lobe epilepsy (TLE)
and to relate binding to histopathology. Methods: The authors studied 16 patients who …

Objectives To investigate whether quantitative T2 mapping is complementary to [18F] FDG
PET in epileptogenic zone detection, thus improving the lateralization accuracy for drug …

In 20% of potential surgical candidates with refractory epilepsy, current optimal MRI does not
identify the cause. GABA is the principal inhibitory neurotransmitter in the brain, and GABAA …

Purpose: Coexistence of hippocampal sclerosis and a potentially epileptogenic cortical
lesion is referred to as dual pathology and can be responsible for poor surgical outcome in …